Long-term outcome of idiopathic XXXX with @entity1985 .

@entity1 @entity644 @entity8 @entity75 @entity177 @entity1985 @entity288
We retrospectively studied 82 consecutive @entity1 with idiopathic @entity8 accepted at two separate Renal Services. These @entity1 had @entity1985 at presentation and had been followed up for at least 10 years. The duration of the disease before renal biopsy ranged between 1 and 18 months. Forty-nine @entity1 never received treatment (non-treated group) whereas 33 @entity1 (treated group) received @entity288 (and cytotoxic agents). The two groups were age and sex matched. There was no difference in clinical findings or in outcome between the two Renal Services. A complete and sustained remission of @entity644 was observed in about 25% of @entity1 , and there was a significant difference (P less than 0.01) between the treated and non-treated group (mean value 39.1% vs 14.3%). Forty-four per cent of the non-treated @entity1 and 24.2% of the treated ones developed @entity177 or @entity8 during a mean potential follow-up of 14 years. @entity8 was recorded in 19.5% of the @entity1 . The staging of the @entity75 represented a very important prognostic index. We confirm, therefore, that idiopathic @entity8 with @entity1985 is frequently a progressive disease. @entity288 (and cytotoxic drugs) seem to be of some benefit in interfering with the natural course of the disease.
